Publications

Tay E, Dymock M, Dawes L, Deng L, Nguyen T, Leeb A, Marsh JA, Wood N, Macartney K, Snelling TL. Short-term safety and adverse event risk profiles for SARS-CoV-2 booster vaccine doses in Australian adults: a survey study. Medical Journal of Australia 2026;224:e70227. doi: 10.5694/mja2.70227. [Full text]

van Hal SJ, Goeman E, Davidson Y, Jenkins F, Whiley D, Lahra M. Neisseria meningitidis MenY ST-1466 harbouring Neisseria gonorrhoeae 16S rRNA allele causing false-positive Aptima® gonococcal nucleic acid amplification test results. Clinical Microbiology and Infection 2026: 32:1187-1189. doi: 10.1016/j.cmi.2026.01.027. [Full text]

Saravanos GL, Takashima M, El-Heneidy A, King C, Ross M, Williams A, Ware RS, Britton PN. Respiratory syncytial virus transmission in closed community settings that include children: a systematic review and meta-analysis. Influenza and Other Respiratory Viruses 2026;20:e70270. doi: 10.1111/irv.70270. [Full text]

McDonald E, Pittet LF, Bonten M, Byrne A, Campbell J, Croda J, Dalcolmo M, Davidson AJ, Dos Santos G, Gardiner K, Gwee A, Jardim B, Lacerda M, Lucas M, Lynn DJ, Manning L, Marshall H, Perrett KP, Prat-Aymerich C, Puga MAM, Richmond P, Rodríguez-Baño J, Wadia U, Warris A, Wood N, Curtis N, Messina NL; BRACE Trial Consortium Group. Optimising COVID-19 episode identification using serology and PCR/rapid antigen testing: insights from the BRACE trial. BMC Infectious Diseases 2026;26:974. doi: 10.1186/s12879-026-13128-6. [Full text]

Simpson A, MacGibbon J, Jackson J, Williamson K, Hammoud M, Holt M, Macartney K, Grulich AE, Beard F. Mpox disease epidemiology, vaccine uptake and vaccination coverage in Australia 2022-2024: a descriptive study. EClinicalMedicine 2026;95:103903. doi: 10.1016/j.eclinm.2026.103903. [Full text]

Nicolopoulos K, van der Kooi S, Chiu C, Hendry A, Macartney K, Gibney K, Flanagan K, Giles M, Crawford N. ATAGI 2025 Annual Statement on Immunisation. Communicable Diseases Intelligence (2018) 2026;50. doi: 10.33321/cdi.2026.50.033. [Full text]

Hull B, Hendry A, Macartney K, Beard F. Annual immunisation coverage report 2024. Communicable Diseases Intelligence (2018) 2026;50. doi: 10.33321/cdi.2026.50.023. [Full text]

Nicolopoulos K, Tran C, Chiu C, Hendry A, Macartney K, Giles M, Crawford N. ATAGI 2024 Annual statement on immunisation.. Communicable Diseases Intelligence (2018) 2026;50. doi: 10.33321/cdi.2026.50.032. [Full text]

Imai-Boulter C, Li-Kim-Moy J, McRae J, Chiu C, Jayasinghe S, Macartney K, Gibney K, Bellamy K, Cooper K, Flanagan K, Giles M, Marshall J, Silberstein N, Teh B, Webby R, Crawford N. ATAGI Targeted Review 2024: immunisation strategies for prevention and control of respiratory syncytial virus disease in Australia. Communicable Diseases Intelligence (2018) 2026;50. doi: 10.33321/cdi.2026.50.034. [Full text]

Churcher LM, Bartlett AW, Pendle S, Slade R, Williams PC. Impact of the BioFire film array meningitis-encephalitis panel on management of suspected paediatric central nervous system infections: a single-centre retrospective cohort study. Journal of Paediatrics and Child Health 2026;62:586-593. doi: 10.1111/jpc.70303. [Full text]